| abstract |
THERAPEUTIC AGENTS, COMBINATION OF SAID AGENTS AND ADDITIONAL THERAPEUTIC AGENT, USE OF SAID AGENTS AND SAID COMBINATION FOR THE MANUFACTURE OF DRUG FOR THE PROPHYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS. The present invention relates to the use of (RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine having formula (IA), or a salt pharmaceutically acceptable form thereof for the formulation of a pharmaceutical composition, useful for the prophylaxis and/or treatment of hyperkinetic movement disorders associated with Huntington's disease, Wilson's disease, Tourette's syndrome, restless leg syndrome, and tardive dyskinesia. |